A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00000976
Recruitment Status : Completed
First Posted : August 31, 2001
Last Update Posted : August 6, 2008
Genentech, Inc.
Information provided by:
National Institute of Allergy and Infectious Diseases (NIAID)